|
Schlusskurs
Swiss Exchange
|
||
| - CHF | - |
|
| 22.07.24 | EU-Kommission verpflichtet Pharmakonzern Vifor zu Gegendarstellung | DP |
| 19.04.24 | Europäische Kommission bittet um Rückmeldung zu den Wettbewerbsverpflichtungen von Vifor Pharma | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.76% | -0.65% | +19.39% | +16.66% | +26.99% | +47.41% | +140.35% | +414.99% | +1’782.65% | 1’216 Mrd. | |
| -1.45% | -1.05% | +7.67% | +5.72% | +31.59% | +46.41% | +79.94% | +66.63% | +136.57% | 656 Mrd. | |
| -2.24% | -0.88% | +8.46% | +17.08% | +26.15% | +32.97% | +103.82% | +145.98% | +414.35% | 509 Mrd. | |
| -2.63% | -5.11% | +9.43% | +4.96% | +16.64% | +44.34% | +61.42% | +4.60% | +70.44% | 384 Mrd. | |
| -2.27% | +0.42% | +5.30% | +14.50% | +39.60% | +74.12% | +42.14% | +80.05% | +149.81% | 362 Mrd. | |
| -2.71% | -2.02% | +11.86% | +4.71% | +19.60% | +28.61% | +55.60% | +72.34% | +89.15% | 311 Mrd. | |
| -3.38% | -2.53% | +13.79% | +14.83% | -1.32% | +6.03% | +32.42% | +45.83% | +207.13% | 293 Mrd. | |
| -3.80% | -0.10% | +14.22% | +12.86% | +40.63% | +43.90% | +70.56% | +115.32% | +239.94% | 249 Mrd. | |
| -3.96% | +1.18% | +15.86% | +27.18% | +36.52% | +36.70% | +105.38% | +152.67% | +131.35% | 208 Mrd. | |
| -0.96% | +1.39% | +9.88% | -8.11% | -17.05% | -12.10% | -61.52% | -26.84% | +134.51% | 180 Mrd. | |
| -2.96% | -0.23% | +9.01% | +15.77% | +20.00% | +21.41% | -4.41% | -38.53% | -0.40% | 170 Mrd. | |
| -1.19% | +0.46% | +7.75% | +11.89% | +19.66% | +30.10% | +44.21% | +181.31% | +587.06% | 138 Mrd. | |
| -1.65% | +2.83% | +7.35% | -0.79% | +17.04% | +35.85% | +19.52% | +6.19% | +23.76% | 129 Mrd. | |
| +0.24% | +9.29% | +17.10% | +22.20% | +30.69% | +26.98% | +136.77% | +383.56% | +719.82% | 124 Mrd. | |
| -2.83% | +3.10% | +16.43% | +10.63% | -0.62% | -3.97% | -3.21% | -6.80% | +13.75% | 114 Mrd. | |
| -6.55% | +8.39% | +18.82% | +329.22% | +718.79% | +924.87% | +211.44% | +1.89% | - | 96.4 Mrd. | |
| -2.45% | -0.49% | +4.56% | -4.67% | +1.18% | +3.80% | +31.39% | -5.22% | -4.66% | 102 Mrd. | |
| -2.98% | +10.28% | +24.29% | +17.48% | +16.98% | +40.16% | +10.53% | +47.64% | +164.48% | 90.6 Mrd. | |
| -2.61% | -2.61% | +6.01% | +1.52% | +20.19% | +33.59% | +0.51% | -29.23% | +59.64% | 73.36 Mrd. | |
| Durchschnitt | -2.31% | +3.19% | +11.96% | +27.03% | +55.96% | +76.90% | +56.68% | +84.86% | +273.30% | 284.43 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -2.61% | +1.23% | +12.44% | +17.43% | +35.60% | +53.06% | +77.53% | +150.36% | +554.26% |
- Börse
- Aktien
- A2DRZ4 Aktie
- Aktie
- Sektor Vifor Pharma
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
